Little is known about risk factors and treatment modalities in Egyptian patients with acute coronary syndrome (ACS). This cross-sectional study was conducted on 200 adult subjects presenting with ACS including ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), or unstable angina to evaluate the pattern of risk factors profile among Egyptian patients with ACS. All patients were subjected to history taking, clinical examination, 12-lead ECG, and plasma troponin I to confirm myocardial necrosis and to identify STEMI, NSTEMI, and unstable angina. The percent of current smokers was significantly higher than non-smokers (63.5% versus 36.5%, p=0.001). History of hypertension was significantly more frequent among the studied patients (57.5% versus 42.5%, p=0.034), and the same was observed for diabetes mellitus (60.5% versus 39.5%, p=0.003). The number of patients having dyslipidemia was significantly higher than those having no dyslipidemia (57% versus 43%, p=0.048). Regarding the body mass index (BMI), high percentages of the studied patients were overweight or obese (40.5% and 37.5%, respectively), with significant differences (p=0.000). The mean LDL was significantly higher in females than males (125.67±34.3 versus 114.68±25.6, p=0.043). Further, the mean BMI was significantly greater in females than males 32.44±5.5 versus 30.38±3.9, p=0.018). Conclusions: The findings of the present study indicated the pattern of modifiable risk factors for ACS Egyptian patients. These included smoking, obesity, hypertension, diabetes mellitus, and dyslipidemia. Lifestyle interventions and awareness of the public are highly recommended for preventing ACS, with especial consideration for women.
Published in | Cardiology and Cardiovascular Research (Volume 6, Issue 4) |
DOI | 10.11648/j.ccr.20220604.12 |
Page(s) | 97-102 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Acute Coronary Syndrome, Dyslipidemia, Egypt, Obesity, Risk Factor, Smoking
[1] | Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Jr., Ganiats, T. G., Holmes, D. R., Jr., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., Levine, G. N., Liebson, P. R., Mukherjee, D., Peterson, E. D., Sabatine, M. S., Smalling, R. W., and Zieman, S. J. (2014). 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 130: e344-426. |
[2] | Puti, E., Rasyid, H., Tandean, P., Sanusi, H., Kasim, H., Bakri, S., Aman, M., and Seweng, A. (2021). High uric acid level increases the risk of acute kidney injury in acute coronary syndrome patients. Caspian J Intern Med. 12: 323-326. |
[3] | Vega, G. L. (2001). Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity, the metabolic syndrome, and cardiovascular disease. American Heart Journal. 142: 1108-1116. |
[4] | Grundy, S. M., Pasternak, R., Greenland, P., Smith, S., Jr., and Fuster, V. (1999). Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 100: 1481-1492. |
[5] | Gupta, A., and Smith, D. A. (2014). The 2013 American College of Cardiology/American Heart Association guidelines on treating blood cholesterol and assessing cardiovascular risk: a busy practitioner's guide. Endocrinology and Metabolism Clinics of North America. 43: 869-892. |
[6] | Mahmood, S. S., Levy, D., Vasan, R. S., and Wang, T. J. (2014). The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 383: 999-1008. |
[7] | Ralapanawa, U., Kumarasiri, P. V. R., Jayawickreme, K. P., Kumarihamy, P., Wijeratne, Y., Ekanayake, M., and Dissanayake, C. (2019). Epidemiology and risk factors of patients with types of acute coronary syndrome presenting to a tertiary care hospital in Sri Lanka. BMC Cardiovasc Disord. 19: 229. |
[8] | Wilson, P. W., D'Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., and Kannel, W. B. (1998). Prediction of coronary heart disease using risk factor categories. Circulation. 97: 1837-1847. |
[9] | Eagle, K. A., Goodman, S. G., Avezum, A., Budaj, A., Sullivan, C. M., and López-Sendón, J. (2002). Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet. 359: 373-377. |
[10] | Fox, K. A., Goodman, S. G., Anderson, F. A., Jr., Granger, C. B., Moscucci, M., Flather, M. D., Spencer, F., Budaj, A., Dabbous, O. H., and Gore, J. M. (2003). From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). European Heart Journal. 24: 1414-1424. |
[11] | Reda, A., Ashraf, M., Soliman, M., Ragy, H., El Kersh, A., Abdou, W., Mostafa, T., Hassan, M., Farag, E., Khamis, H., Wadie, M., Elbahry, A., Salama, S., Kazamel, G., Sadaka, M., Mostafa, M., Abd El-Bary, A., Sanad, O., Rafla, S., Abd El-Hady, Y., Selim, M., Farag, N., El-Ghawaby, H., El-Araby, H., Emil, S., Beshay, M., Shawky, A., Yusef, M., Abd El-Ghany, M., Gamal, A., Baghdady, Y., Mostafa, T., Zahran, M., El Rabat, K., Bendary, A., and El Shorbagy, A. (2019). The pattern of risk-factor profile in Egyptian patients with acute coronary syndrome: phase II of the Egyptian cross-sectional CardioRisk project. Cardiovasc J Afr. 30: 87-94. |
[12] | Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., Reiner, Ž., Riccardi, G., Taskinen, M. R., Tokgozoglu, L., Verschuren, W. M., Vlachopoulos, C., Wood, D. A., and Zamorano, J. L. (2016a). 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 253: 281-344. |
[13] | Jellinger, P. S., Smith, D. A., Mehta, A. E., Ganda, O., Handelsman, Y., Rodbard, H. W., Shepherd, M. D., and Seibel, J. A. (2012). American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocrine Practice. 18 Suppl 1: 1-78. |
[14] | Wakabayashi, I. (2013). Necessity of both waist circumference and waist-to-height ratio for better evaluation of central obesity. Metabolic Syndrome and Related Disorders. 11: 189-194. |
[15] | Keates, A. K., Mocumbi, A. O., Ntsekhe, M., Sliwa, K., and Stewart, S. (2017). Cardiovascular disease in Africa: epidemiological profile and challenges. Nat Rev Cardiol. 14: 273-293. |
[16] | Mensah, G. A., Roth, G. A., Sampson, U. K., Moran, A. E., Feigin, V. L., Forouzanfar, M. H., Naghavi, M., and Murray, C. J. (2015). Mortality from cardiovascular diseases in sub-Saharan Africa, 1990-2013: a systematic analysis of data from the Global Burden of Disease Study 2013. Cardiovasc J Afr. 26: S6-10. |
[17] | Goodman, S. G., Huang, W., Yan, A. T., Budaj, A., Kennelly, B. M., Gore, J. M., Fox, K. A. A., Goldberg, R. J., and Anderson, F. A. (2009). The expanded Global Registry of Acute Coronary Events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. American Heart Journal. 158: 193-201. e195. |
[18] | Čeponienė, I., Žaliaduonytė-Pekšienė, D., Gustienė, O., Tamošiūnas, A., and Žaliūnas, R. (2014). Association of major cardiovascular risk factors with the development of acute coronary syndrome in Lithuania. European heart journal supplements: journal of the European Society of Cardiology. 16: A80-A83. |
[19] | Leviner, D. B., Zafrir, B., Jaffe, R., Saliba, W., Flugelman, M. Y., and Sharoni, E. (2020). Impact of Modifiable Risk Factors on Long-Term Outcomes after Coronary Artery Bypass Surgery. Thorac Cardiovasc Surg. |
[20] | Musaiger, A. O. (2011). Overweight and obesity in eastern mediterranean region: prevalence and possible causes. Journal of obesity. 2011: 407237-407237. |
[21] | Hamidi, S., and Akinci, F. (2016). Measuring Efficiency of Health Systems of the Middle East and North Africa (MENA) Region Using Stochastic Frontier Analysis. Appl Health Econ Health Policy. 14: 337-347. |
[22] | Piché, M. E., Poirier, P., Lemieux, I., and Després, J. P. (2018). Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update. Prog Cardiovasc Dis. 61: 103-113. |
[23] | Itoh, H., Kaneko, H., Kiriyama, H., Kamon, T., Fujiu, K., Morita, K., Michihata, N., Jo, T., Takeda, N., Morita, H., Yasunaga, H., and Komuro, I. (2021). Metabolically Healthy Obesity and the Risk of Cardiovascular Disease in the General Population - Analysis of a Nationwide Epidemiological Database. Circ J. 85: 914-920. |
[24] | Koliaki, C., Liatis, S., and Kokkinos, A. (2019). Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 92: 98-107. |
[25] | Petrie, J. R., Guzik, T. J., and Touyz, R. M. (2018). Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol. 34: 575-584. |
[26] | Berman, A. N., and Blankstein, R. (2019). Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options. Curr Cardiol Rep. 21: 110. |
[27] | Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., Delling, F. N., Djousse, L., Elkind, M. S. V., Ferguson, J. F., Fornage, M., Jordan, L. C., Khan, S. S., Kissela, B. M., Knutson, K. L., Kwan, T. W., Lackland, D. T., Lewis, T. T., Lichtman, J. H., Longenecker, C. T., Loop, M. S., Lutsey, P. L., Martin, S. S., Matsushita, K., Moran, A. E., Mussolino, M. E., O'Flaherty, M., Pandey, A., Perak, A. M., Rosamond, W. D., Roth, G. A., Sampson, U. K. A., Satou, G. M., Schroeder, E. B., Shah, S. H., Spartano, N. L., Stokes, A., Tirschwell, D. L., Tsao, C. W., Turakhia, M. P., VanWagner, L. B., Wilkins, J. T., Wong, S. S., and Virani, S. S. (2019). Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 139: e56-e528. |
[28] | Rognoni, A., Cavallino, C., Veia, A., Bacchini, S., Rosso, R., Facchini, M., Secco, G. G., Lupi, A., Nardi, F., Rametta, F., and Bongo, A. S. (2015). Pathophysiology of Atherosclerotic Plaque Development. Cardiovasc Hematol Agents Med Chem. 13: 10-13. |
[29] | Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., Reiner, Ž., Riccardi, G., Taskinen, M. R., Tokgozoglu, L., Verschuren, W. M., Vlachopoulos, C., Wood, D. A., and Zamorano, J. L. (2016b). [2016 ESC/EAS Guidelines for the Management of Dyslipidaemias]. Kardiol Pol. 74: 1234-1318. |
[30] | Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., Goldberg, R., Heidenreich, P. A., Hlatky, M. A., Jones, D. W., Lloyd-Jones, D., Lopez-Pajares, N., Ndumele, C. E., Orringer, C. E., Peralta, C. A., Saseen, J. J., Smith, S. C., Jr., Sperling, L., Virani, S. S., and Yeboah, J. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 73: 3168-3209. |
[31] | Raal, F. J., Alsheikh-Ali, A. A., Omar, M. I., Rashed, W., Hamoui, O., Kane, A., Alami, M., Abreu, P., and Mashhoud, W. M. (2018). Cardiovascular risk factor burden in Africa and the Middle East across country income categories: a post hoc analysis of the cross-sectional Africa Middle East Cardiovascular Epidemiological (ACE) study. Arch Public Health. 76: 15. |
[32] | Khraishah, H., Alahmad, B., Alfaddagh, A., Jeong, S. Y., Mathenge, N., Kassab, M. B., Kolte, D., Michos, E. D., and Albaghdadi, M. (2021). Sex disparities in the presentation, management and outcomes of patients with acute coronary syndrome: insights from the ACS QUIK trial. Open heart. 8: e001470. |
[33] | Appelman, Y., van Rijn, B. B., Ten Haaf, M. E., Boersma, E., and Peters, S. A. (2015). Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis. 241: 211-218. |
APA Style
Ahmed El Kersh, Ashraf Reda, Ahmed Samir. (2022). The Risk Factor Profile in Egyptian Patients with Acute Coronary Syndrome: An Observational Study. Cardiology and Cardiovascular Research, 6(4), 97-102. https://doi.org/10.11648/j.ccr.20220604.12
ACS Style
Ahmed El Kersh; Ashraf Reda; Ahmed Samir. The Risk Factor Profile in Egyptian Patients with Acute Coronary Syndrome: An Observational Study. Cardiol. Cardiovasc. Res. 2022, 6(4), 97-102. doi: 10.11648/j.ccr.20220604.12
@article{10.11648/j.ccr.20220604.12, author = {Ahmed El Kersh and Ashraf Reda and Ahmed Samir}, title = {The Risk Factor Profile in Egyptian Patients with Acute Coronary Syndrome: An Observational Study}, journal = {Cardiology and Cardiovascular Research}, volume = {6}, number = {4}, pages = {97-102}, doi = {10.11648/j.ccr.20220604.12}, url = {https://doi.org/10.11648/j.ccr.20220604.12}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20220604.12}, abstract = {Little is known about risk factors and treatment modalities in Egyptian patients with acute coronary syndrome (ACS). This cross-sectional study was conducted on 200 adult subjects presenting with ACS including ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), or unstable angina to evaluate the pattern of risk factors profile among Egyptian patients with ACS. All patients were subjected to history taking, clinical examination, 12-lead ECG, and plasma troponin I to confirm myocardial necrosis and to identify STEMI, NSTEMI, and unstable angina. The percent of current smokers was significantly higher than non-smokers (63.5% versus 36.5%, p=0.001). History of hypertension was significantly more frequent among the studied patients (57.5% versus 42.5%, p=0.034), and the same was observed for diabetes mellitus (60.5% versus 39.5%, p=0.003). The number of patients having dyslipidemia was significantly higher than those having no dyslipidemia (57% versus 43%, p=0.048). Regarding the body mass index (BMI), high percentages of the studied patients were overweight or obese (40.5% and 37.5%, respectively), with significant differences (p=0.000). The mean LDL was significantly higher in females than males (125.67±34.3 versus 114.68±25.6, p=0.043). Further, the mean BMI was significantly greater in females than males 32.44±5.5 versus 30.38±3.9, p=0.018). Conclusions: The findings of the present study indicated the pattern of modifiable risk factors for ACS Egyptian patients. These included smoking, obesity, hypertension, diabetes mellitus, and dyslipidemia. Lifestyle interventions and awareness of the public are highly recommended for preventing ACS, with especial consideration for women.}, year = {2022} }
TY - JOUR T1 - The Risk Factor Profile in Egyptian Patients with Acute Coronary Syndrome: An Observational Study AU - Ahmed El Kersh AU - Ashraf Reda AU - Ahmed Samir Y1 - 2022/11/10 PY - 2022 N1 - https://doi.org/10.11648/j.ccr.20220604.12 DO - 10.11648/j.ccr.20220604.12 T2 - Cardiology and Cardiovascular Research JF - Cardiology and Cardiovascular Research JO - Cardiology and Cardiovascular Research SP - 97 EP - 102 PB - Science Publishing Group SN - 2578-8914 UR - https://doi.org/10.11648/j.ccr.20220604.12 AB - Little is known about risk factors and treatment modalities in Egyptian patients with acute coronary syndrome (ACS). This cross-sectional study was conducted on 200 adult subjects presenting with ACS including ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), or unstable angina to evaluate the pattern of risk factors profile among Egyptian patients with ACS. All patients were subjected to history taking, clinical examination, 12-lead ECG, and plasma troponin I to confirm myocardial necrosis and to identify STEMI, NSTEMI, and unstable angina. The percent of current smokers was significantly higher than non-smokers (63.5% versus 36.5%, p=0.001). History of hypertension was significantly more frequent among the studied patients (57.5% versus 42.5%, p=0.034), and the same was observed for diabetes mellitus (60.5% versus 39.5%, p=0.003). The number of patients having dyslipidemia was significantly higher than those having no dyslipidemia (57% versus 43%, p=0.048). Regarding the body mass index (BMI), high percentages of the studied patients were overweight or obese (40.5% and 37.5%, respectively), with significant differences (p=0.000). The mean LDL was significantly higher in females than males (125.67±34.3 versus 114.68±25.6, p=0.043). Further, the mean BMI was significantly greater in females than males 32.44±5.5 versus 30.38±3.9, p=0.018). Conclusions: The findings of the present study indicated the pattern of modifiable risk factors for ACS Egyptian patients. These included smoking, obesity, hypertension, diabetes mellitus, and dyslipidemia. Lifestyle interventions and awareness of the public are highly recommended for preventing ACS, with especial consideration for women. VL - 6 IS - 4 ER -